These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 25916577)
1. Matrix metalloproteinases as therapeutic targets for stroke. Yang Y; Rosenberg GA Brain Res; 2015 Oct; 1623():30-8. PubMed ID: 25916577 [TBL] [Abstract][Full Text] [Related]
2. Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Morancho A; Rosell A; García-Bonilla L; Montaner J Ann N Y Acad Sci; 2010 Oct; 1207():123-33. PubMed ID: 20955435 [TBL] [Abstract][Full Text] [Related]
3. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799 [TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases in human spontaneous intracerebral hemorrhage: an update. Florczak-Rzepka M; Grond-Ginsbach C; Montaner J; Steiner T Cerebrovasc Dis; 2012; 34(4):249-62. PubMed ID: 23052179 [TBL] [Abstract][Full Text] [Related]
5. Multiphasic roles for matrix metalloproteinases after stroke. Rosell A; Lo EH Curr Opin Pharmacol; 2008 Feb; 8(1):82-9. PubMed ID: 18226583 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and free radicals in cerebral ischemia. Jian Liu K; Rosenberg GA Free Radic Biol Med; 2005 Jul; 39(1):71-80. PubMed ID: 15925279 [TBL] [Abstract][Full Text] [Related]
7. Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease. Meisel JE; Chang M Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):2001-2014. PubMed ID: 28435009 [TBL] [Abstract][Full Text] [Related]
8. Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke. Kimura-Ohba S; Yang Y Oxid Med Cell Longev; 2016; 2016():6927328. PubMed ID: 26925194 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibition in atherosclerosis and stroke. Roycik MD; Myers JS; Newcomer RG; Sang QX Curr Mol Med; 2013 Sep; 13(8):1299-313. PubMed ID: 23865428 [TBL] [Abstract][Full Text] [Related]
10. Matrix metaloproteinases activity during the evolution of hypoxic-ischemic brain damage in the immature rat. The effect of 1-methylnicotinamide (MNA). Dragun P; Makarewicz D; Wójcik L; Ziemka-Nałecz M; Słomka M; Zalewska T J Physiol Pharmacol; 2008 Sep; 59(3):441-55. PubMed ID: 18953089 [TBL] [Abstract][Full Text] [Related]
11. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study. Mroczko B; Groblewska M; Barcikowska M J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694 [TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079 [TBL] [Abstract][Full Text] [Related]
13. [Matrix metaloproteinases in neurological brain lesions: a new therapeutic target?]. Vilalta A; Sahuquillo Barris J; Poca MA Rev Neurol; 2010 Jul; 51(2):95-107. PubMed ID: 20602315 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases in neuroinflammation. Rosenberg GA Glia; 2002 Sep; 39(3):279-91. PubMed ID: 12203394 [TBL] [Abstract][Full Text] [Related]
15. [The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy]. Naduk-Kik J; Hrabec E Postepy Hig Med Dosw (Online); 2008 Sep; 62():442-50. PubMed ID: 18772849 [TBL] [Abstract][Full Text] [Related]
16. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Rosell A; Alvarez-Sabín J; Arenillas JF; Rovira A; Delgado P; Fernández-Cadenas I; Penalba A; Molina CA; Montaner J Stroke; 2005 Jul; 36(7):1415-20. PubMed ID: 15947272 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Gueders MM; Foidart JM; Noel A; Cataldo DD Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964 [TBL] [Abstract][Full Text] [Related]
18. Role of matrix metalloproteinases in animal models of ischemic stroke. Lenglet S; Montecucco F; Mach F Curr Vasc Pharmacol; 2015; 13(2):161-6. PubMed ID: 24188490 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and the thyroid. Kraiem Z; Korem S Thyroid; 2000 Dec; 10(12):1061-9. PubMed ID: 11201850 [TBL] [Abstract][Full Text] [Related]